News
The Potential of Vinpocetine in the Treatment of Cardiovascular Diseases
Vinpocetine is a nootropic indicated for the symptomatic treatment of cerebral ischemic hypoperfusion, vascular dementia, and reducing the psychological and neurological consequences of cerebral blood supply disorders. Due to its excellent safety profile, tolerance, and complex mechanism of action, it is currently being studied in experimental models of various disorders such as obesity and cardiovascular (CV) diseases including atherosclerosis, neointimal hyperplasia, vasoconstriction, pathological heart remodeling, and ischemic stroke…
Artificial Intelligence in Breast Cancer Detection – Results from Real Clinical Practice
A study conducted in Sweden examined the use of artificial intelligence (AI) in the detection of…
Efficacy of Luspatercept in 1st Line Treatment of Anemia Due to Low-Risk Myelodysplastic Syndrome
A planned interim analysis of the COMMANDS study showed a greater benefit of the innovative…
HPD 2024: Czech data from real-world practice confirm that mucolytic treatment can reduce COPD exacerbations, even in the future
Chronic obstructive pulmonary disease (COPD) is a global issue. Does it create the same burden…
HPD 2024: Bronchitis as an Early Feature of PreCOPD, Role of Mucus Plugs in COPD, and New Findings on Their Exacerbations
Exacerbations of chronic obstructive pulmonary disease (COPD) significantly affect disease…
Benefit of Oral Semaglutide for Patients with Type 2 Diabetes in the General Practitioner's Office
Oral semaglutide is a modern antidiabetic suitable within primary care for people with type 2 diabetes,...
Targeting HER2 is Clinically Meaningful Even with Its Low Expression
Distinguishing HER2 receptor expression status on the surface of breast cancer tumor cells as…
A device the size of a matchbox will help treat obstructive sleep apnea
Obstructive sleep apnea, also known as sleep apnea syndrome, is the second most common sleep…
Current Recommendations of the International League Against Epilepsy for the Treatment of Seizures in Newborns
In 2023, a team of experts in neurology, neonatology, and pediatrics, along with representatives of…
Epilepsy with Generalized Tonic-Clonic Seizures in an Adolescent Patient – A Case Study
This is the story of Anička, a 16-year-old girl who has been treated for epilepsy since she was 14.…